Ceribell (CBLL) Other Non-Current Liabilities (2023 - 2026)
Ceribell (CBLL) posted Other Non-Current Liabilities of $106000.0 for Q1 2026, little changed on a QoQ basis from $106000.0 in Q4 2025, and little changed year-over-year from $106000.0 in Q1 2025.
Ceribell (CBLL) Other Non-Current Liabilities (2023 - 2026) Analysis & Trends
Ceribell's Other Non-Current Liabilities history runs 4 years deep, the most recent figure standing at $106000.0 for Q1 2026.
- Quarterly Other Non-Current Liabilities changed 0.0% year-over-year to $106000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $106000.0 (changed 0.0% YoY) and the FY2025 annual result came in at $106000.0, down 70.22% from the prior year.
- Other Non-Current Liabilities was $106000.0 for Q1 2026 at Ceribell, roughly flat from $106000.0 in the prior quarter.
- Across five years, Other Non-Current Liabilities topped out at $1.4 million in Q3 2024 and bottomed at $106000.0 in Q1 2025.
- A 4-year average of $342250.0 and a median of $106000.0 in 2025 frame the typical range for Other Non-Current Liabilities.
- Annual changes were most pronounced in 2025 — Other Non-Current Liabilities plunged 92.49% — and 2026, when it changed 0.0%.
- Ceribell's Other Non-Current Liabilities stood at $441000.0 in 2023, then declined by 19.27% to $356000.0 in 2024, then plunged by 70.22% to $106000.0 in 2025, then changed by 0.0% to $106000.0 in 2026.
- Business Quant data shows CBLL's Other Non-Current Liabilities at $106000.0 in Q1 2026, $106000.0 in Q4 2025, and $106000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Ceribell | 613.16 Mn | 471.97 Mn | 23.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 106,000.00 |
| Dec 31, 2025 | 106,000.00 |
| Sep 30, 2025 | 106,000.00 |
| Jun 30, 2025 | 106,000.00 |
| Mar 31, 2025 | 106,000.00 |
| Dec 31, 2024 | 356,000.00 |
| Sep 30, 2024 | 1.41 Mn |
| Dec 31, 2023 | 441,000.00 |